微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2024-09-30 | 1.9% | -34.93% | 90% | 101/160 | 4.14% | 百利天恒 | 186.1% | 行业排名> |
| 2024-06-30 | 1% | -18.03% | 14.94% | 103/160 | 2.6% | 百利天恒 | 186.89% | 行业排名> |
| 2024-03-31 | 0.87% | -54.21% | -42% | 95/160 | 2.3% | 百利天恒 | 188.56% | 行业排名> |
| 2023-12-31 | 1.5% | 194.12% | -48.63% | 94/160 | -0.96% | 小方制药 | 41.8% | 行业排名> |
| 2023-09-30 | 2.92% | 183.5% | 139.34% | 94/160 | 2.37% | 拓新药业 | 20.51% | 行业排名> |
| 2023-06-30 | 1.22% | 205% | -35.79% | 101/160 | 1.51% | 拓新药业 | 19.87% | 行业排名> |
| 2023-03-31 | 1.9% | 3266.67% | 272.55% | 64/160 | 1.38% | 拓新药业 | 19.91% | 行业排名> |
| 2022-12-31 | 0.51% | 106.66% | -50.49% | 107/160 | 0.8% | 小方制药 | 55.57% | 行业排名> |
| 2022-09-30 | 1.03% | -96.11% | 157.5% | 106/160 | 2.89% | 福元医药 | 25.41% | 行业排名> |
| 2022-06-30 | 0.4% | 127.4% | 766.67% | 113/160 | 2.24% | 小方制药 | 34.81% | 行业排名> |
| 2022-03-31 | -0.06% | -100.22% | 99.22% | 115/160 | 1.61% | 退市金泰 | 10.74% | 行业排名> |
| 2021-12-31 | -7.66% | -554.7% | -128.91% | 129/160 | 0.94% | 人福医药 | 6.82% | 行业排名> |
| 2021-09-30 | 26.5% | 2108.33% | 1915.07% | 2/160 | 4.53% | 小方制药 | 71.99% | 行业排名> |
| 2021-06-30 | -1.46% | -67.82% | -105.37% | 120/160 | 2.99% | 汇宇制药 | 39.25% | 行业排名> |
| 2021-03-31 | 27.17% | 1470.52% | 2422.22% | 1/160 | 2.52% | 汇宇制药 | 28.14% | 行业排名> |
| 2020-12-31 | -1.17% | -119.5% | -197.5% | 115/160 | 3.74% | 哈三联 | 27.17% | 行业排名> |
| 2020-09-30 | 1.2% | -84.98% | 237.93% | 96/160 | 3.22% | 汇宇制药 | 55.94% | 行业排名> |
| 2020-06-30 | -0.87% | -124.58% | -150.29% | 110/160 | 4.24% | 河化股份 | 45.32% | 行业排名> |
| 2020-03-31 | 1.73% | -36.63% | -71.17% | 56/160 | 2.24% | 汇宇制药 | 31.9% | 行业排名> |
| 2019-12-31 | 6% | -4% | -24.91% | 81/160 | 2.78% | 誉衡药业 | 35.56% | 行业排名> |
| 2019-09-30 | 7.99% | -16.6% | 125.71% | 47/160 | 7.61% | 奥赛康 | 35% | 行业排名> |
| 2019-06-30 | 3.54% | 13.1% | 29.67% | 66/160 | 5.05% | 奥赛康 | 28.15% | 行业排名> |
| 2019-03-31 | 2.73% | -18.02% | -56.32% | 39/160 | 2.46% | 宏源药业 | 21.91% | 行业排名> |
| 2018-12-31 | 6.25% | -58.8% | -34.76% | 76/160 | 7.09% | 奥赛康 | 9.7% | 行业排名> |
| 2018-09-30 | 9.58% | -36.93% | 206.07% | 27/160 | 7.26% | 奥赛康 | 40.69% | 行业排名> |
| 2018-06-30 | 3.13% | -66.2% | -6.01% | 66/160 | 4.65% | 信立泰 | 25.93% | 行业排名> |
| 2018-03-31 | 3.33% | -61.01% | -78.05% | 23/160 | 2.55% | 昂利康 | 15.91% | 行业排名> |
| 2017-12-31 | 15.17% | -29.41% | -0.13% | 25/160 | 9.66% | 奥赛康 | 12.08% | 行业排名> |
| 2017-09-30 | 15.19% | 2% | 64.04% | 14/160 | 8.31% | 一品红 | 31.62% | 行业排名> |
| 2017-06-30 | 9.26% | 2% | -56.91% | 18/160 | 5.59% | 丽珠集团 | 49.43% | 行业排名> |
| 2016-12-31 | 21.49% | -7.37% | -7.37% | 21/160 | 6.33% | 河化股份 | 54.24% | 行业排名> |
| 2015-12-31 | 23.2% | -10.04% | 171.66% | 18/160 | 11.35% | 华东医药 | 7.2% | 行业排名> |
| 2015-03-31 | 8.54% | 2% | -66.89% | 4/160 | 2.41% | 南新制药 | 81.7% | 行业排名> |